Caladrius Pulse, August 2026: Consent, Claims Economics, and ABDM on the Ground

The monthly Caladrius roundup. In July we published a reading list of the ten most recent Caladrius Pulse explainers on ABHA, ABDM, NHCX and the registries beneath them. This is the first of what will now be a monthly follow-up: each month we summarise everything Caladrius Health has published since our last edition, so you can track India’s digital-health story without checking the feed yourself. Every summary links straight to the original.

This edition covers five new articles, the three published in August 2026, plus two from late July that landed after our mid-month reading list went out (so nothing slips through the cracks). Read together, they mark a clear shift in the Caladrius Pulse story. The earlier run of explainers answered “what are these systems?” This batch asks the harder, more grown-up questions: who controls the data, where does the money actually go, why is it still slow, and why does the same national mission look so different from one state to the next?

The five cluster into two threads. Two pieces are about the patient and consent layer, how ABDM puts people in control of their records, and what that control feels like at a hospital front desk. Three are about the economics and the ground truth, where India’s health-claims money went, why settlement is still slow, and how unevenly ABDM has actually landed across states. Here they are, newest first.

1. Where ABDM Adoption Stands, State by State

The most quietly important piece of the month. ABDM is centrally designed but federally implemented, the National Health Authority sets the architecture, but state governments do the actual work, and this article argues that the resulting variation is structural, not a temporary league table of winners and laggards. The record-linkage leaders as of 22 May 2026 tell the story: Uttar Pradesh with 15.03 crore ABHA-linked records, Andhra Pradesh 11.95 crore, Bihar 7.37 crore, Rajasthan 6.32 crore, Gujarat 4.77 crore, against a national total of 100 crore linked records. But the piece’s sharpest move is to separate volume from functional interoperability: as of 6 February 2025, 363,520 facilities were registered on the HFR yet fewer than half, 159,020, actually ran ABDM-enabled software, and only about 2% of 35 crore linked reports came from private providers, even though private hospitals hold roughly 70% of the market. It uses three states as a framework: Uttar Pradesh hit scale by routing its own eKavach platform through ABDM (Scan-and-Share reached 792 public facilities, cutting OPD registration from 30-40 minutes to 5-10); Tamil Nadu, with a state HMIS since 2008, now faces the legacy-integration problem of connecting old systems rather than building new ones; and Kerala, with eHealth live statewide since 2017, must wire an existing clinical base into ABDM’s consent layer. The takeaway for anyone operating across states: national compliance is not a plan, you need a state-specific roadmap, and “high linked-record counts” is not the same as “records that actually move as FHIR.”

🔗 Read it: caladriushealth.ai/blog/2026/08/25/Where-ABDM-Adoption-Stands

2. Why Your Insurance Claim Takes So Long, And What’s Changing

The plain-language companion to the money piece below. Its diagnosis of the delay is memorable: the system “evolved one insurer, one hospital and one portal at a time, efficient in pieces, slow as a whole.” Because insurers and TPAs each run separate portals with inconsistent formats, hospitals re-key the same information repeatedly, and a single missing diagnosis code, signature, or investigation report bounces the request back and restarts the clock. As of early 2024 only 63% of customers used cashless treatment; the rest fell back on the reimbursement route, which runs 30-45 days. The article then lays out what is genuinely changing. The IRDAI Master Circular (May 2024) mandates pre-authorisation decisions within 1 hour and discharge approval within 3 hours, with hospitals absorbing the cost if insurers miss the deadline, and compliance data from August 2024 to May 2025 shows it is largely working (86.9% met the 1-hour benchmark, 96.7% the 3-hour one). The “Cashless Everywhere” initiative (January 2024) extends cashless treatment to any eligible hospital, not just network ones. And NHCX, live since July 2024, is framed not as yet another portal but as a “common language” that standardises claim formatting across every participant, removing the re-entry and document-chasing that cause most delay. The practical patient advice is worth repeating: link your ABHA before admission, request pre-authorisation early, and treat the IRDAI timelines as entitlements, not courtesies.

🔗 Read it: caladriushealth.ai/blog/2026/08/07/Why-Insurance-Claim-Takes-So-Long

3. Where India’s Health Claims Money Went: A Verified Data Reference

A reference article rather than an essay, and all the more useful for it. Caladrius consolidates verified public data, each figure traced to a named regulatory source, to give an industry that “lacks standardised reference points” a set of credible benchmarks. The headline anatomy of FY 2023-24: India processed roughly ₹1.17 lakh crore in health claims, of which ₹83,493 crore (71.29%) was paid, ₹15,100 crore (12.9%) disallowed, ₹10,937 crore (9.34%) repudiated, and ₹7,585 crore (6.48%) left pending at year end. Put differently, 22.3% of claim value faced rejection and 28.7% went unpaid within the reporting year. By count, insurers settled 2.69 of 3.26 crore claims (82.46%), at an average payout of ₹31,086. The article insists on a distinction most coverage blurs, disallowed (the insurer declines to process) versus repudiated (denied after review for policy non-compliance), because the two point to very different fixes. It sets this against a fast-growing market: health premiums hit ₹1,07,681 crore in FY 2023-24 (up 20.32%) and crossed ₹1.27 lakh crore in FY 2024-25, now 41.42% of all non-life insurance, with Grand View Research projecting USD 46.37 billion by 2030 at a 20.9% CAGR, and a revenue-cycle-management market of USD 4-5.4 billion riding on top. Bookmark this one; it’s the number-source you’ll reach for when someone asks “how big is the leakage, really?”

🔗 Read it: caladriushealth.ai/blog/2026/08/03/where-indias-health-claims-money-went

4. Your ABHA Is Ready. Here’s What Changes the Next Time You Visit a Hospital

The most human piece of the batch, told through a patient named Meera to show what the infrastructure actually feels like at the point of care. The thesis is that a live, linked ABHA quietly removes friction: registration happens by scanning a QR code (with implied consent), and the doctor opens your prior context instead of a blank form, the article’s lovely phrase is that care shifts from “restart” to “resume.” It grounds the optimism in numbers: ABHA coverage rose from 32.7% to 53.9% of the population between January 2024 and July 2025, and an adoption study of 425 OPD attendees (September 2024-April 2025) probed the digital-literacy barriers that still hold people back. It’s also candid about where ABHA doesn’t yet help, financial clarity for planned procedures. It introduces pre-determination (giving patients a coverage estimate up front) as the emerging complement to pre-authorisation (the insurer’s treatment approval), and reminds readers that out-of-pocket surprises usually come from room-rent sub-limits, co-payments, deductibles and non-medical exclusions rather than outright denial. Useful entitlements to know, all reiterated here: cashless pre-authorisation within 1 hour, discharge within 3 hours, settlement within 30 days, and pre-existing-disease waiting periods capped at 36 months since April 2024. A good article to send anyone who has just created an ABHA and wondered what it’s actually for.

🔗 Read it: caladriushealth.ai/blog/2026/07/30/how-to-use-abha-at-a-hospital

5. Consent by Design: How ABDM Puts Patients in Control of Their Health Data

The most architecturally important read of the month, and a natural bridge to the compliance conversation every builder is now having. Its thesis: ABDM implements data sovereignty through a federated, consent-first design rather than a central store, the Health Information Exchange and Consent Manager (HIE-CM) routes records between Health Information Providers and Users only against a machine-readable consent artefact that specifies purpose, data categories, frequency, duration and expiry, and is revocable (though the article is honest that revocation “depends on timely propagation and individual providers’ system compliance, rather than happening instantaneously”). The scale context is striking: 93.95 crore ABHA accounts as of July 2026 and 105 crore linked records, with the record count doubling from 50 crore (February 2025) to over 100 crore in just 15 months, atop 5.33 lakh HFR facilities and 9.85 lakh HPR professionals. But the heart of the piece is governance. It maps the Health Data Management Policy (December 2020, revised April 2022), which mandates explicit, granular, revocable consent with cryptographically signed audit trails, onto the broader Digital Personal Data Protection Act (2023), whose 2025 Rules require compliance by May 2027 and carry penalties up to ₹250 crore for security failures. It notes the narrow non-consensual carve-outs under DPDPA Section 7 (medical emergencies and specific public-health mandates only, commercial use excluded), and contrasts India’s approach with GDPR: rather than a health-specific special category, India governs health data through ABDM’s operational HDMP plus the sector-agnostic DPDPA. The compliance takeaway is a standing one: every data-sharing transaction must trace to a valid consent artefact, audit traceability and revocation handling are continuous obligations, not one-time checkboxes.

🔗 Read it: caladriushealth.ai/blog/2026/07/22/Consent-By-Design

The through-line

Put the five together and a maturity curve appears. India spent the last few years proving it could create the rails, 93.95 crore ABHA accounts, 105 crore linked records, a live NHCX. This month’s writing is about what happens once the rails exist: consent becomes a legal obligation with a 2027 deadline and ₹250-crore teeth; claims economics come into focus with hard numbers on where ₹1.17 lakh crore actually goes; the patient experience turns “surprisingly ordinary”; and adoption reveals itself as a state-by-state story where routing volume through a gateway is the easy part and functional FHIR interoperability is the real work. That gap, between records linked and records that genuinely move and mean something, is exactly the layer Yajur Healthcare works on. For the earlier explainers that set up all of this, see our July reading list; for the claims side specifically, our note on why digitisation alone couldn’t fix India’s health-claims ecosystem.

For the full, continually-updated feed, follow Caladrius Pulse directly, and watch this space next month.